165 related articles for article (PubMed ID: 27369688)
21. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
22. Duloxetine-induced nocturnal bruxism resolved by buspirone: case report.
Albayrak Y; Ekinci O
Clin Neuropharmacol; 2011; 34(4):137-8. PubMed ID: 21768799
[TBL] [Abstract][Full Text] [Related]
23. Upper gastrointestinal bleeding due to overdose of selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory drugs.
Sanz Segura P; García Cámara P; Gotor Delso J; Monzón Báez RM; Llorente Barrio M; Fernández Bonilla E; Bernal Monterde V
Gastroenterol Hepatol; 2019 Dec; 42(10):622-623. PubMed ID: 31324464
[No Abstract] [Full Text] [Related]
24. Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.
Bymaster FP; Beedle EE; Findlay J; Gallagher PT; Krushinski JH; Mitchell S; Robertson DW; Thompson DC; Wallace L; Wong DT
Bioorg Med Chem Lett; 2003 Dec; 13(24):4477-80. PubMed ID: 14643350
[TBL] [Abstract][Full Text] [Related]
25. Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis.
Ranieri M; Putignano P; Fiore P; Santamato A; Megna G; Bellomo RG; Cristella G; Saggini R; Megna M
Int J Immunopathol Pharmacol; 2012; 25(1 Suppl):51S-56S. PubMed ID: 22652162
[TBL] [Abstract][Full Text] [Related]
26. Duloxetine-induced hypomania: case report and brief review of the literature on SNRIs-induced mood switching.
Peritogiannis V; Antoniou K; Mouka V; Mavreas V; Hyphantis TN
J Psychopharmacol; 2009 Jul; 23(5):592-6. PubMed ID: 18562441
[TBL] [Abstract][Full Text] [Related]
27. Duloxetine-induced excessive disturbing and disabling yawning.
De Las Cuevas C; Sanz EJ
J Clin Psychopharmacol; 2007 Feb; 27(1):106-7. PubMed ID: 17224733
[No Abstract] [Full Text] [Related]
28. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
[TBL] [Abstract][Full Text] [Related]
29. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
Rabasseda X
Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
[TBL] [Abstract][Full Text] [Related]
30. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
[TBL] [Abstract][Full Text] [Related]
32. Combination of lithium and duloxetine in 2 depressed patients refractory to duloxetine monotherapy.
Steffenhagen N; Kürstein B; Kirkby KC; Himmerich H
Pharmacopsychiatry; 2011 Mar; 44(2):72-4. PubMed ID: 21161884
[No Abstract] [Full Text] [Related]
33. Efficacy, tolerability, and safety of duloxetine.
Wise TN
CNS Spectr; 2005 Dec; 10(12 Suppl 19):10-1. PubMed ID: 18841598
[No Abstract] [Full Text] [Related]
34. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
[TBL] [Abstract][Full Text] [Related]
35. Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report.
Albayrak Y; Ekinci O
J Clin Psychopharmacol; 2012 Oct; 32(5):723-4. PubMed ID: 22926615
[No Abstract] [Full Text] [Related]
36. Effects of duloxetine on painful physical symptoms associated with depression.
Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
[TBL] [Abstract][Full Text] [Related]
37. Duloxetine-induced hypertensive urgency in type 2 diabetes mellitus with diabetic neuropathy.
Shukla R; Khasbage S; Garg MK; Singh S
Indian J Pharmacol; 2020; 52(3):213-215. PubMed ID: 32874005
[TBL] [Abstract][Full Text] [Related]
38. Hyponatremia Induced by Duloxetine: A Case Report.
Hu D; Wurster S
Consult Pharm; 2018 Aug; 33(8):446-449. PubMed ID: 30068437
[TBL] [Abstract][Full Text] [Related]
39. Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States.
Beard SM; Roskell N; Le TK; Zhao Y; Coleman A; Ang D; Lawson K
J Med Econ; 2011; 14(4):463-76. PubMed ID: 21651426
[TBL] [Abstract][Full Text] [Related]
40. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.
Raskin J; Wang F; Pritchett YL; Goldstein DJ
Pain Med; 2006; 7(5):373-85. PubMed ID: 17014595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
